| | Publication Year | Title | Author(s) |
| 1 | 13-Nov-2023 | Antibody drug conjugates for glioblastoma: current progress toward clinical use. | Gan, Hui K ; Parakh, Sagun ; Osellame, Laura D; Cher, Lawrence M ; Uccellini, Anthony; Hafeez, Umbreen ; Menon, Siddharth; Scott, Andrew M |
| 2 | Sep-2023 | Acute Toxicity of Hypofractionated and Conventionally Fractionated (Chemo)Radiotherapy Regimens for Bladder Cancer: An Exploratory Analysis from the RAIDER Trial. | Huddart, R; Hafeez, S ; Omar, A; Alonzi, R; Birtle, A; Cheung, K C; Choudhury, A; Foroudi, Farshad ; Gribble, H; Henry, A; Hilman, S; Hindson, B; Lewis, R; Muthukumar, D; McLaren, D B; McNair, H; Nikapota, A; Olorunfemi, A; Parikh, O; Philipps, L; Rimmer, Y; Syndikus, I; Tolentino, A; Varughese, M; Vassallo-Bonner, C; Webster, A; Griffin, C; Hall, E |
| 3 | 2023 | Thymic Carcinoid in a Patient with Concurrent Manifestations of Multiple Endocrine Neoplasia Type 1. | Zhu, Jasmine J ; Dean, Samantha; Hafeez, Umbreen ; Neoh, Sandra L |
| 4 | 22-Aug-2022 | Correction to: Poor correlation between preclinical and patient efficacy data for tumor targeted monotherapies in glioblastoma: the results of a systematic review. | Gunjur, Ashray ; Balasubramanian, Adithya ; Hafeez, Umbreen ; Menon, Siddharth; Cher, Lawrence M ; Parakh, Sagun ; Gan, Hui K |
| 5 | 6-Aug-2022 | Poor correlation between preclinical and patient efficacy data for tumor targeted monotherapies in glioblastoma: the results of a systematic review. | Gunjur, Ashray ; Balasubramanian, Adithya ; Hafeez, Umbreen ; Menon, Siddharth; Cher, Lawrence M ; Parakh, Sagun ; Gan, Hui K |
| 6 | Jan-2021 | Inefficiencies in phase II to phase III transition impeding successful drug development in glioblastoma. | Balasubramanian, Adithya ; Gunjur, Ashray ; Hafeez, Umbreen ; Menon, Siddharth; Cher, Lawrence M ; Parakh, Sagun ; Gan, Hui K |
| 7 | Dec-2020 | New insights into ErbB3 function and therapeutic targeting in cancer. | Hafeez, Umbreen ; Parslow, Adam C; Gan, Hui K ; Scott, Andrew M |
| 8 | 16-Oct-2020 | Antibody-Drug Conjugates for Cancer Therapy. | Hafeez, Umbreen ; Parakh, Sagun ; Gan, Hui K ; Scott, Andrew M |
| 9 | Dec-2019 | Biomarkers and smart intracranial devices for the diagnosis, treatment, and monitoring of high-grade gliomas: a review of the literature and future prospects. | Hafeez, Umbreen ; Cher, Lawrence M |
| 10 | Oct-2019 | Young adults diagnosed with high grade gliomas: Patterns of care, outcomes, and impact on employment. | Hafeez, Umbreen ; Menon, Siddarth; Nguyen, Bella; Lum, Caroline; Gaughran, Gregory; Pranavan, Ganesalingham; Cher, Lawrence; Nowak, Anna K; Gan, Hui K ; Parakh, Sagun |
| 11 | 5-Jun-2018 | Monoclonal antibodies as immunomodulatory therapy against cancer and autoimmune diseases. | Hafeez, Umbreen ; Gan, Hui K ; Scott, Andrew M |
| 12 | 2018 | Emerging Gene Fusion Drivers in Primary and Metastatic Central Nervous System Malignancies: A Review of Available Evidence for Systemic Targeted Therapies. | Brastianos, Priscilla K; Ippen, Franziska Maria; Hafeez, Umbreen ; Gan, Hui K |